In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
no speaker photo
Speaker
Svetlana Boldueva
Svetlana Boldueva Svetlana Boldueva

North-Western State Medical University named after I.I. Mechnikov, Saint Petersburg (Russian Federation)

Specialities : Acute Coronary Syndromes , Coronary Artery Disease Chronic, Risk Factors and Prevention

23 presentations from this speaker

Analysis of cases of type 2 myocardial infarction in a multidisciplinary clinic

Event : Acute Cardiovascular Care 2019

  • Session : Acute Coronary Syndromes – Epidemiology, Prognosis, Outcome
  • Speaker : S Boldueva (Saint-Petersburg,RU)

Evaluation of in-hospital and 2-years follow-up outcomes in patients with myocardial infarction after manual thrombaspiration

Event : Acute Cardiovascular Care 2019

  • Session : Acute Coronary Syndromes: Treatment, Revascularization
  • Speaker : S Boldueva (Saint-Petersburg,RU)

Evaluation of the nociceptive flexor reflex, as a new method for the diagnosis of microvascular angina

Event : ESC Congress 2019

  • Session : Risk factors for Coronary Artery Disease
  • Speaker : S Boldueva (Saint-Petersburg,RU)

Polymorphism rs776746 in the gene of cyp3a5 is able to us for predicting of clinical efficiency of bisoprolol in patients with acute coronary syndromec

Event : Acute Cardiovascular Care 2019

  • Session : Acute Coronary Syndromes: Biomarkers, Pharmacotherapy and Prevention
  • Speaker : S Boldueva (Saint-Petersburg,RU)

Predictors of success of biofeedback in the rehabilitation of patients after acute myocardial infarction.

Event : ESC Congress 2019

  • Session : Cardiovascular rehabilitation
  • Speaker : S Boldueva (Saint-Petersburg,RU)

Clinical case of heart failure due to neoplastic origin in women with uterus adenocarcinoma

Event : Heart Failure 2018

  • Session : Acute Heart Failure - Clinical
  • Speaker : S Boldueva (Saint-Petersburg,RU)

Clinical case of Takotsubo cardiomyopathy as an acute form of microvascular angina

Event : Heart Failure 2018

  • Session : Acute Heart Failure - Clinical
  • Speaker : S Boldueva (Saint-Petersburg,RU)

Manual thromboaspiration in patients with myocardial infarction: in-hospital assessment of class of heart failure and systolic function

Event : Heart Failure 2018

  • Session : Coronary Artery Disease – Treatment
  • Speaker : S Boldueva (Saint-Petersburg,RU)

Predictors of cardiac death due to progression of chronic heart failure in patients after myocardial infarction

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : S Boldueva (Saint-Petersburg,RU)

Takotsubo syndrome as a form of an acute variant of primary microvascular angina

Event : Heart Failure 2018

  • Session : Acute Heart Failure - Clinical
  • Speaker : S Boldueva (Saint-Petersburg,RU)

Different clinical variants of primary microvascular angina

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2017

  • Session : Epidemiology/ Public health_Part 1
  • Speaker : S Boldueva (Saint-Petersburg,RU)

Effects of trimetazidine in therapy of microvascular angina

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2017

  • Session : Exercise testing/ training/ Cardiac Rehabilitation_Part 1
  • Speaker : S Boldueva (Saint-Petersburg,RU)

Genetic polymorphisms of Lys198Asn gene endothelin -1 and ins319G gene as a protective factor in the pathogenesis of microvascular angina

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2017

  • Session : Epidemiology/ Public health_Part 2
  • Speaker : S Boldueva (Saint-Petersburg,RU)

Impaired glucose tolerance in young and middle-aged women with coronary artery disease: the preventive role of ABCA1 gene polymorphism InsG319

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2017

  • Session : Epidemiology/ Public health_Part 2
  • Speaker : S Boldueva (Saint-Petersburg,RU)

Predicting of sudden cardiac death after acute myocardial infarction. Do left ventricular remodeling and inflammation play important role?

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2017

  • Session : Epidemiology/ Public health_Part 3
  • Speaker : S Boldueva (Saint-Petersburg,RU)

The prognostic model of risk of coronary artery disease among young and middle age women, including traditional, biochemical and genetic factors

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2017

  • Session : Epidemiology/ Public health_Part 2
  • Speaker : S Boldueva (Saint-Petersburg,RU)

Young and middle-aged women with coronary artery disease: traditional and genetic (polymorphism C825T gene beta-3-subunit of G protein (GNB3)) risk factors

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2017

  • Session : Risk factors: others_Part 2
  • Speaker : S Boldueva (Saint-Petersburg,RU)

Heart failure as a factor of unfavorable prognosis for women with myocardial infarction

Event : Heart Failure 2016

  • Session : Prognosis
  • Speaker : S Boldueva (Saint-Petersburg,RU)

Risk stratification of sudden cardiac death among patients with myocardial infarction and ventricular arrhythmias

Event : Acute Cardiovascular Care 2016

  • Session : Risk Stratification
  • Speaker : S Boldueva (Saint-Petersburg,RU)

The level of sudden and non-sudden cardiac death in patients after myocardial infarction:what happened from 90-th to present time

Event : Acute Cardiovascular Care 2016

  • Session : Sudden death / resuscitation
  • Speaker : S Boldueva (Saint-Petersburg,RU)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are